Ortho-McNeil Pharmaceutical

Ortho-McNeil Pharmaceutical was a pharmaceutical company that was a subsidiary of Johnson & Johnson. The company was known for developing and manufacturing a wide range of pharmaceutical products, with a focus on medications for various medical conditions.

History

Ortho-McNeil Pharmaceutical was founded in the early 20th century and quickly established itself as a leading pharmaceutical company. Over the years, the company developed a reputation for producing high-quality medications that were used to treat a variety of health issues.

Products

Ortho-McNeil Pharmaceutical produced a diverse range of pharmaceutical products, including medications for pain relief, cardiovascular health, and mental health. Some of the company's most well-known products included Tylenol, a popular over-the-counter pain reliever, and Risperdal, a medication used to treat schizophrenia and bipolar disorder.

Research and Development

Ortho-McNeil Pharmaceutical was committed to investing in research and development to create innovative new medications. The company worked closely with healthcare professionals and researchers to develop treatments that could improve the lives of patients suffering from various medical conditions.

Acquisition by Johnson & Johnson

In 1993, Ortho-McNeil Pharmaceutical was acquired by Johnson & Johnson, a multinational healthcare company. Following the acquisition, Ortho-McNeil Pharmaceutical continued to operate as a subsidiary of Johnson & Johnson, leveraging the resources and expertise of its parent company to further its research and development efforts.

Legacy

Although Ortho-McNeil Pharmaceutical is no longer an independent entity, its legacy lives on through the medications it developed and the impact it had on the pharmaceutical industry. Many of the products originally created by Ortho-McNeil Pharmaceutical are still in use today, helping patients around the world manage their health conditions.